KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $2.90 $4.87 Friday, 27th Jan 2023 CLBS stock ended at $3.55. This is 1.14% more than the trading day before Thursday, 26th Jan 2023. During the day the stock fluctuated 1.43% from a day low at $3.50 to a day high of $3.55.
90 days $2.90 $4.87
52 weeks $0.402 $9.75

Historical Caladrius Biosciences prices

Date Open High Low Close Volume
Aug 04, 2020 $2.34 $2.55 $2.25 $2.45 514 585
Aug 03, 2020 $2.27 $2.42 $2.27 $2.35 269 966
Jul 31, 2020 $2.42 $2.46 $2.27 $2.27 402 339
Jul 30, 2020 $2.12 $2.44 $2.12 $2.37 622 023
Jul 29, 2020 $2.14 $2.22 $2.05 $2.16 612 627
Jul 28, 2020 $2.33 $2.42 $2.10 $2.17 819 326
Jul 27, 2020 $2.48 $2.48 $2.26 $2.35 939 247
Jul 24, 2020 $2.49 $2.57 $2.35 $2.46 649 447
Jul 23, 2020 $2.55 $2.67 $2.42 $2.47 1 008 230
Jul 22, 2020 $2.61 $2.66 $2.46 $2.53 755 900
Jul 21, 2020 $2.79 $2.80 $2.61 $2.66 1 248 700
Jul 20, 2020 $2.63 $2.71 $2.51 $2.63 1 618 700
Jul 17, 2020 $2.44 $2.81 $2.40 $2.58 2 970 700
Jul 16, 2020 $2.47 $2.51 $2.35 $2.50 938 200
Jul 15, 2020 $2.71 $2.80 $2.38 $2.48 1 848 600
Jul 14, 2020 $2.28 $3.21 $2.22 $3.00 6 527 800
Jul 13, 2020 $2.06 $2.22 $2.02 $2.16 928 600
Jul 10, 2020 $1.98 $2.07 $1.92 $2.03 338 500
Jul 09, 2020 $2.14 $2.24 $1.92 $2.00 1 125 100
Jul 08, 2020 $2.02 $2.15 $1.98 $2.12 929 800
Jul 07, 2020 $1.83 $1.98 $1.76 $1.97 698 100
Jul 06, 2020 $1.79 $1.83 $1.75 $1.80 208 000
Jul 02, 2020 $1.78 $1.82 $1.75 $1.75 142 373
Jul 01, 2020 $1.78 $1.85 $1.75 $1.77 285 974
Jun 30, 2020 $1.82 $1.82 $1.74 $1.78 272 523
Click to get the best stock tips daily for free!

About Caladrius Biosciences

Caladrius Biosciences Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical limb ischemia; XOWNA that is in Phase IIb clinical trial for the treatment of coronary microvascular dysf... CLBS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT